Income Statement
FRACTYL HEALTH, INC.
GUTS
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY |
|---|---|---|
|
Revenue
|
- | - |
|
Cost of Revenue
|
0.00 | 0.05 |
|
Gross Profit
|
0.00 | 0.04 |
|
Operating Expenses
|
96.82 | 93.57 |
|
Research & Development
|
74.54 | 70.47 |
|
Selling, General & Administrative
|
22.28 | 23.10 |
|
Other Operating Expenses
|
- | - |
|
Operating Income
|
-96.82 | -93.53 |
|
Non-Operating Income
|
-44.14 | 24.84 |
|
Interest Income
|
1.54 | 4.15 |
|
Interest Expense
|
- | - |
|
Other Non-Op Income / Expense
|
-0.05 | -0.05 |
|
Income Before Tax
|
- | - |
|
Income Tax Expense
|
- | - |
|
Non-Controlling Interest
|
- | - |
|
Net Income
|
-140.95 | -68.69 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY |
|---|---|---|
|
Depreciation & Amortization
|
- | - |
|
EBITDA
|
-96.82 | -93.53 |
|
Earnings Per Share (Basic)
|
-1.86 | -1.62 |
|
Diluted EPS
|
-1.86 | -1.62 |
|
Weighted Average Shares
|
75.82 | 43.54 |
|
Diluted Weighted Avg Shares
|
75.82 | 43.54 |
|
Comprehensive Income
|
- | - |